International Clinical Trial: A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462780) titled 'A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants' on March 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Shenzhen Kangzhe Biotechnology Co., Ltd.

Condition: Paroxysmal Nocturnal Hemoglobinuria, PNH Complement-mediated Kidney Disease

Intervention: Drug: CMS-D017 Capsule Drug: CMS-D017 Placebo Capsule Drug: CMS-D017 Capsule

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: ...